Endovia Health Sciences (EDVA) Revenue (2012 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Revenue (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.41 Bn | 133.56 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 86.45 Bn | 78.45 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.90 Bn | 59.71 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 57.46 Bn | 52.32 Bn | 52.00 Mn | 145.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.26 Bn | 35.16 Bn | 1.53 Bn | 1.71 Bn |
| 7 | Alnylam Pharmaceuticals | 35.43 Bn | 32.12 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Royalty Pharma | 28.06 Bn | 27.22 Bn | - | 674.14 Mn |
| 9 | Insmed | 27.30 Bn | 26.14 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Endovia Health Sciences | 812,506.32 | 569,804.32 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 4,224.00 |
| Dec 31, 2025 | -365,206.00 |
| Sep 30, 2025 | 393,072.00 |
| Jun 30, 2025 | -23,406.00 |
| Mar 31, 2025 | 68,606.00 |
| Dec 31, 2024 | -2.77 Mn |
| Sep 30, 2024 | 981,859.00 |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 2.69 Mn |
| Sep 30, 2023 | 5.14 Mn |
| Jun 30, 2023 | 5.19 Mn |
| Mar 31, 2023 | 5.82 Mn |
| Dec 31, 2022 | 4.79 Mn |
| Sep 30, 2022 | 4.87 Mn |
| Jun 30, 2022 | 4.50 Mn |
| Mar 31, 2022 | 3.93 Mn |
| Dec 31, 2021 | 2.74 Mn |
| Sep 30, 2021 | 2.95 Mn |
| Jun 30, 2021 | 3.44 Mn |